LOGIN  |  REGISTER
Amneal Pharmaceuticals
Astria Therapeutics

MultiPlan Wins “Achievement in Data and Analytics” Category of the 2024 Globee® Awards for American Business

June 26, 2024 | Last Trade: US$7.04 0.02 0.28
  • Company’s PlanOptix™ and BenInsights™ solutions recognized for reducing healthcare costs

NEW YORK / Jun 26, 2024 / Business Wire / MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced it has been selected as the Gold award winner in the “Achievement in Data and Analytics” category of the 9th annual Globee® Awards for American Business.

MultiPlan’s PlanOptix™ and BenInsights™ solutions were selected for their impact on driving excess costs and overpayments out of the healthcare system. We believe this award is a testament to how our data-driven services are improving price transparency, reining in healthcare costs, increasing accessibility, and delivering effective customized healthcare cost management programs.

“MultiPlan is dedicated to bending the cost curve in healthcare and we're honored to be recognized by the Globee® Awards for the work we’re doing to address this industry challenge,” said Travis Dalton, President and CEO of MultiPlan. “We’re guided by the belief that the best way to improve patient health outcomes is to drive optimal benefit plan design and reduce the total cost of care, and our award-winning solutions like PlanOptix™ and BenInsights™ are a testament to that.”

The Globee® Awards for American Business is a prestigious award program recognizing outstanding achievements and commitments to excellence and innovation across various categories in American business. Known for celebrating outstanding achievements across various sectors, this awards program has recognized MultiPlan for its significant contributions and dedication to pushing the boundaries of what is possible. MultiPlan was selected from a highly competitive pool of entries, highlighting its dedication to excellence and commitment to delivering exceptional value to the healthcare industry.

To learn more about PlanOptix™ and BenInsights™, visit: https://www.multiplan.us/data-decision-science-services/

About MultiPlan

MultiPlan is committed to bending the cost curve in healthcare by delivering transparency, fairness, and affordability to the US healthcare system. Our focus is on identifying medical savings, helping to lower out-of-pocket costs, and reducing or eliminating balance billing for healthcare consumers. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets clients’ needs and customizes innovative solutions that combine its payment and revenue integrity, network-based, data and decision science, and analytics-based services. MultiPlan delivers value to more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit multiplan.com.

About the Globee® Awards

Globee® Awards are conferred in ten programs and competitions: the Globee® Awards for American Business, Globee® Awards for Artificial Intelligence, Globee® Awards for Business, Globee® Awards for Customer Excellence, Globee® Awards for Cybersecurity, Globee® Awards for Disruptors, Golden Bridge Awards®, Globee® Awards for Leadership, Globee® Awards for Technology, and the Globee® Awards for Women In Business. Learn more about the Globee Awards at https://globeeawards.com

Follow us on Twitter: @globeeawards #globeeawards #americanbusiness

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB